Hypertrophic cardiomyopathy: a practical approach to guideline directed management.
Full text not available from this repository.| Item Type: | Review |
|---|---|
| Status: | Published |
| Official URL: | https://doi.org/10.1016/S0140-6736%2821%2901205-8 |
| Journal or Publication Title: | The Lancet |
| Volume: | 398 |
| Number: | 10316 |
| Page Range: | pp. 2102-2108 |
| Date: | 2021 |
| Divisions: | Molecular Cardiology |
| Depositing User: | General Admin |
| Identification Number: | 10.1016/S0140-6736(21)01205-8 |
| ISSN: | 01406736 |
| Date Deposited: | 17 Mar 2022 01:37 |
| Abstract: | Hypertrophic cardiomyopathy, one of the most common genetic cardiovascular conditions, will be encountered by nearly every health-care provider regardless of specialty. In 2020, new hypertrophic cardiomyopathy management guidelines were published, updating and evolving preceding versions. This Seminar provides a concise review and practical guide to the updated recommendations for patients with hypertrophic cardiomyopathy. |
| Creators: | Creators Email Ommen, Steve R UNSPECIFIED Semsarian, Christopher UNSPECIFIED |
| Last Modified: | 17 Mar 2022 01:37 |
| URI: | https://eprints.centenary.org.au/id/eprint/1194 |
Actions (login required)
 |
View Item |
